Back to search

Ireland· IE-PA-PPA0465/507/001

Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension

A mometason, kombinationen product containing mometasone furoate + olopatadine, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 10 of our 19 countries.

ATC R01AD59

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRyaltris 25 microgram/actuation + 600…ATCR01AD59REGISTER NO.IE-PA-PPA0465/507/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Mometason, kombinationen is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AD59 (mometason, kombinationen), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Mometason, kombinationen · ATC R01AD59

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Mometasone furoate + Olopatadine
Manufacturer
PCO Manufacturing Ltd.
Country
Ireland (IE)
ATC code
R01AD59
ATC class
Mometason, Kombinationen
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PPA0465/507/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mometason, kombinationen in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mometason, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Ryaltris
  • Belgium · Ryaltris
  • Czechia · Ryaltris
  • Germany · Ryaltris
  • Denmark · Ryaltris
  • Spain · Ryaltris
  • Finland · Ryaltris
  • France · Ryaltris
  • United Kingdom (Northern Ireland) · Ryaltris
  • Italy · Rineffix, Ryaltris
  • Lithuania · Ryaltris
  • Luxembourg · Ryaltris
  • Latvia · Ryaltris
  • Malta · Ryaltris
  • Netherlands · Ryaltris
  • Norway · Ryaltris
  • Poland · Ryaltris
  • Romania · Ryaltris
  • Sweden · Mometasone Furoate/Olopatadine Glenmark, Ryaltris
  • Slovakia · Ryaltris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f6ac456-de9b-4bee-b92e-5e8888ac5ac9
GET /v1/drugs/3f6ac456-de9b-4bee-b92e-5e8888ac5ac9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, suspension",
  "routes": [
    "Nasal use"
  ],
  "source": "hpra",
  "atc_all": [
    "R01AD59"
  ],
  "strength": null,
  "pa_number": "PPA0465/507/001",
  "substances": [
    "Mometasone furoate",
    "Olopatadine"
  ],
  "legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
  "market_info": "Unknown",
  "authorised_at": "12/07/2024",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about mometason, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.